Marketed as a "4+++ generation" fighter, the MiG-35 debuted in 2007 ... states for the platform. The Fulcrum-F was displayed alongside the Boeing F/A-18E/F Super Hornet, Eurofighter Typhoon ...

Russia's MiG-35 Fighter Looks to Be 'Headed ... acquire client states for the platform. The Fulcrum-F was displayed alongside the Boeing F/A-18E/F Super Hornet, Eurofighter Typhoon, Dassault ...

In a major fillip to eco-friendly mode of public transport, the Telangana State Road Transport Corporation (TGSRTC) on Sunday launched a fleet of 35 super luxury electric buses on Karimnagar ...

Generally speaking, these helicopters are grouped together within the HiP-H family, much like the MiG-29 and MiG-35 Fulcrum ...

The MiG-41, also known as PAK DP ... or at least delay it. The F-35 Lightning II stealth fighter jet is a good example of such an aircraft. It is extremely difficult to combine speed ...

Fulcrum Therapeutics (NASDAQ:FULC) announced Thursday after its lead program for protein kinase inhibitor losmapimod, in-licensed from GSK (GSK), failed to reach main goals in patients with a rare ...

CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company ...

Fulcrum Therapeutics Inc. (NASDAQ:FULC) stock is trading lower on Thursday after the company released data from the Phase 3 REACH trial evaluating losmapimod in patients with Facioscapulohumeral ...

Just four months after Sanofi bet $80 million in upfront cash on Fulcrum Therapeutics’ losmapimod, the program has ended in a phase 3 failure. The licensing deal with the Big Pharma was agreed ...

Fulcrum Therapeutics, Inc.'s stock plummeted over 60% after its lead candidate, losmapimod, failed to meet primary and secondary endpoints in a Phase 3 study for FSHD. Despite prior optimism and ...